Skip to Content

Tag Archives: DRG

MAJOR BOTTOM FOR DRUG STOCKS?

For a number of weeks, P/E ratios (and other valuation yardsticks) for the big-name pharmaceutical stocks have shriveled to multiyear lows. Now we seem to be approaching a downside climax.